BioSpace News Archive

Mobile Imaging Services Market: At Home Diagnostic Testing May Boost the Mobile Imaging Services in the Near Future

According to the report, the global mobile imaging services market was valued at US$ 12,510.7 Mn in 2018 and is anticipated to expand at a CAGR of 2.7% from 2019 to 2027

December 15, 2020
·
4 min read
Dental 3D Printing Market: Growing Demand for Dental Care Boost Market Growth

According to the report, the global dental 3D printings market was valued at US$ 1.4 Bn in 2018 and is anticipated to expand at a CAGR of 14.5% from 2019 to 2027

December 15, 2020
·
5 min read
Biotech Bay

Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca® (Filgotinib)

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq: GLPG) today announced that the companies have agreed to amend their existing arrangement for the commercialization and development of Jyseleca (filgotinib).

December 15, 2020
·
16 min read
Business

Rafael Holdings Reports First Quarter Fiscal Year 2021 Results

Rafael Holdings, Inc., reported revenue of $1.1 million and a loss per share of $0.09 for the first quarter of its 2021 fiscal year, the three months ended October 31, 2020.

December 15, 2020
·
9 min read
Biotech Bay

Protagonist Therapeutics, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Protagonist Therapeutics, Inc. (Nasdaq: PTGX), a clinical stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 5,476,189 shares of its common stock

December 15, 2020
·
2 min read
Twistle Deploys First COVID-19 Vaccine Communication Pathways at Two Large Health Systems

Twistle is pleased to announce that the first of its COVID-19 vaccine administration pathways is now live at two large health systems in the western United States, including HonorHealth.

December 15, 2020
·
2 min read
Deals

NANOBIOTIX Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $113.3 Million

NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the initial closing of its previously announced initial public offering on the Nasdaq Global Select Market by way of a capital increase of 7,300,000 new ordinary shares

December 15, 2020
·
9 min read
Drug Development

vTv Therapeutics Announces Topline Results of Phase 2 Elevage Study of Azeliragon in Patients with Mild Alzheimer’s Disease and Type 2 Diabetes

vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that the Phase 2 Elevage study of azeliragon in people with mild Alzheimer’s disease and type 2 diabetes did not meet its primary objective of demonstrating an improvement in cognition as assessed by the 14-item Alzheimer’s Disease Assessment Scale – Cognitive Subscale (ADAS-cog14) relative to placebo.

December 15, 2020
·
3 min read
Deals

Viatris Inc. Recommends Caution on TRC Capital Corp.'s Attempt to Acquire Shares at a Significant Discount via Mini-Tender Offer

Viatris Inc. has been notified of an unsolicited “mini-tender” offer by TRC Capital Corporation to purchase up to 6,000,000 shares, or approximately 0.497 percent, of the outstanding common stock of Viatris at a price of $16.50 per share in cash.

December 15, 2020
·
3 min read
Deals

Scopus BioPharma Announces Pricing of Initial Public Offering

Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the pricing of its initial public offering.

December 15, 2020
·
3 min read